News

March 9, 2018

Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology
INDIANAPOLIS, March 9, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Maura Dickler, M.D., a prestigious breast cancer researcher, will join Lilly Oncology as Vice President of Late Phase Development on May 7, 2018.  Dr. Dickler is currently the Section Head, Endocrine Therapy Clinical Research Program at Memori...

December 11, 2017

Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology
INDIANAPOLIS, Dec. 11, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Kimberly Blackwell, M.D., one of the nation's leading breast cancer researchers, will join Lilly Oncology as vice president of early phase development and immuno-oncology on March 12, 2018.  Dr. Blac...

November 13, 2017

Lilly Appoints Philip Johnson to Senior Vice President and Treasurer
INDIANAPOLIS, Nov. 13, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Philip Johnson has been appointed to senior vice president, Finance, and treasurer effective January 1, 2018. Johnson currently serves as vice president for Investor Relations at Lilly. He will report to Joshua Smiley, who will become senior vice president...

October 23, 2017

Lilly announces $72 million investment in diabetes manufacturing in Indianapolis
INDIANAPOLIS, Oct. 23, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to invest $72 million in an insulin manufacturing project at one of its Indianapolis facilities. The investment will be used to replace an existing insulin vial filling line and allow Lilly to meet growing demand for its insulins - including Humalog&...

Showing 1-4 of 4 Page: 1